← Leaderboards
Ruxana T Sadikot
Omaha Va Medical Center
$780,000
Attributed
$1,560,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $390K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,560,000 · 1
VA$0 · 1
By mechanism
R01$1,560,000 · 1
I01$0 · 1
Top collaborators
- David Marshall Guidot4 shared
Others in their field
Top investigators on “Host Defense”
- Barton F Haynes · Duke University$108,110,105
- Joseph B. Margolick · Johns Hopkins University$57,387,310
- Donald Ym Leung · University Of Colorado Denver$48,856,677
- Alice Telesnitsky · University Of Michigan At Ann Arbor$48,088,158
- Robert L Modlin · University Of California Los Angeles$39,897,663
- Michael J Gale · University Of Texas Sw Med Ctr/Dallas$32,634,819
Research focus
Host DefensePseudomonas AeruginosaInfectionLungIn VivoImmuneImmune ResponseMolecularSignal TransductionInnate Immune ResponseFunctional DisorderResponseProteinsClinical TrialsTranslatingEpithelial CellsLigandsGenesPathogenAttenuatedVeteransNovel Therapeutic InterventionNovel TherapeuticsLung Injury
Grant awards (16)
PGC-1 alpha in Lung Immune Response$0
I01 · FY2025 · VA · contact PI
PGC-1 alpha in Lung Immune Response$0
I01 · FY2024 · VA · contact PI
PGC-1 alpha in Lung Immune Response$0
I01 · FY2023 · VA · contact PI
How HIV-related proteins increase the susceptibility to lung injury despite anti-retroviral therapy$390,000
R01 · FY2022 · HL
How HIV-related proteins increase the susceptibility to lung injury despite anti-retroviral therapy$390,000
R01 · FY2021 · HL
PPARgamma agonism in lung immune response$0
I01 · FY2021 · VA · contact PI
How HIV-related proteins increase the susceptibility to lung injury despite anti-retroviral therapy$390,000
R01 · FY2020 · HL · contact PI
PPARgamma agonism in lung immune response$0
I01 · FY2020 · VA · contact PI
How HIV-related proteins increase the susceptibility to lung injury despite anti-retroviral therapy$390,000
R01 · FY2019 · HL · contact PI
PPARgamma agonism in lung immune response$0
I01 · FY2019 · VA · contact PI
PPARgamma agonism in lung immune response$0
I01 · FY2018 · VA · contact PI
TREM-1 in Lung Immune Response$0
I01 · FY2016 · VA · contact PI
TREM-1 in Lung Immune Response$0
I01 · FY2015 · VA · contact PI
TREM-1 in Lung Immune Response$0
I01 · FY2015 · VA · contact PI
TREM-1 in Lung Immune Response$0
I01 · FY2014 · VA · contact PI
TREM-1 in Lung Immune Response$0
I01 · FY2013 · VA · contact PI